May 22, 2026 05:15PM
May 22, 2026 05:15PM
May 21, 2026 06:30AM
May 21, 2026 06:30AM
May 21, 2026 06:02AM
May 21, 2026 06:00AM
Apr 9, 2026 08:45AM Immix Biopharma to Participate in the Jefferies Global Healthcare Conference
Mar 30, 2026 08:47AM
Mar 30, 2026 08:45AM
Mar 25, 2026 04:44AM
Mar 3, 2026 08:45AM
Jan 28, 2026 08:45AM
Jan 28, 2026 08:45AM
Dec 9, 2025 05:45PM Immix Biopharma completes $100 million stock offering
Dec 9, 2025 05:45PM
Dec 7, 2025 06:20PM
Dec 7, 2025 06:20PM
Dec 7, 2025 06:15PM
Dec 7, 2025 06:15PM
Nov 12, 2025 08:45AM
Nov 12, 2025 08:45AM Immix Biopharma Appoints Chief Commercial Officer to Drive NXC-201 Launch
Nov 3, 2025 08:45AM
Nov 3, 2025 08:45AM
Nov 3, 2025 08:45AM
Nov 3, 2025 08:45AM
Oct 14, 2025 08:45AM
Oct 6, 2025 04:05PM
Oct 1, 2025 08:45AM Immix Biopharma to Present at the 37th Annual Piper Sandler Healthcare Conference
Sep 18, 2025 01:30PM
Sep 18, 2025 01:30PM
Sep 11, 2025 09:15AM
Sep 11, 2025 09:15AM
Sep 8, 2025 04:05PM
Sep 8, 2025 04:05PM
Aug 25, 2025 09:30AM Immix Biopharma to Present at the Stifel 2025 Healthcare Conference
Aug 6, 2025 12:31PM
Aug 6, 2025 12:30PM
Jul 11, 2025 09:36AM
Jul 11, 2025 09:36AM
Jul 8, 2025 06:51AM
Jul 7, 2025 09:35AM
Jul 7, 2025 09:35AM Immix Biopharma Announces Accelerated NEXICART-2 Clinical Trial Progress in relapsed/refractory AL Amyloidosis
Jun 6, 2025 09:39AM
Jun 3, 2025 02:56PM
Jun 3, 2025 02:55PM
May 23, 2025 09:06AM
May 23, 2025 09:05AM
May 22, 2025 04:05PM
May 22, 2025 04:02PM Immix Biopharma Announces Positive Results for NXC-201 at ASCO Oral Presentation, Enabling Pathway to Best-in-Class Therapy for relapsed/refractory AL Amyloidosis
May 21, 2025 04:03PM

322,996 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All